WASHINGTON – Johnson & Johnson, which makes health products from Band-Aids to biologic drugs, spent nearly $1.7 million in the third quarter lobbying on the health care overhaul and multiple bills that could boost its sales or lower taxes, according to a recent disclosure form.

This article is a premium content source. You must be Registered and Logged In to view the entire article.

Registration is 100% free and only takes a few seconds. Please Register Now.